The AI is being used in the discovery and design of next-generation GLP-1 analogs
GLP-1, says Kunal Shah, MD, an assistant professor in the division of endocrinology at the Rutgers Robert Wood Johnson Medical Center
What should I bring to my appointment
S-1-propenylcysteine improves TNF--induced vascular endothelial barrier dysfunction by suppressing the GEF-H1/RhoA/Rac pathway
Phase 2 Trial Data, What Researchers Are Working From The pivotal Phase 2 trial (Jastreboff et al., NEJM 2023, NCT04881760) enrolled 338 adults across six cohorts over 48 weeks
For example, the LEADER trial showed that Liraglutide significantly reduced the risk of major adverse cardiovascular events (MACE) by 13% and cardiovascular death by 22% in comparison to placebo